Treatment of Bacterial Meningitis
The recommended empirical treatment for bacterial meningitis in adults is ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours, with additional agents based on patient age and risk factors. 1
Empirical Treatment Algorithm
For Adults <60 Years:
- Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 2, 1
- If penicillin-resistant pneumococci is suspected (e.g., recent travel to areas with high resistance rates), add vancomycin 15-20mg/kg IV twice daily OR rifampicin 600mg twice daily 2
For Adults ≥60 Years:
- Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 2, 1
- PLUS amoxicillin 2g IV every 4 hours (for Listeria coverage) 2, 1
- Consider adding co-trimoxazole 10-20mg/kg (of trimethoprim component) in four divided doses as an alternative to amoxicillin 2
Pathogen-Specific Treatment
Streptococcus pneumoniae:
- If penicillin-sensitive (MIC ≤0.06 mg/L): Benzylpenicillin 2.4g IV every 4 hours OR continue ceftriaxone/cefotaxime 2, 1
- If penicillin-resistant but cephalosporin-sensitive: Continue ceftriaxone/cefotaxime 2
- If both penicillin and cephalosporin-resistant: Continue ceftriaxone/cefotaxime PLUS vancomycin 15-20mg/kg IV twice daily PLUS rifampicin 600mg twice daily 2
- Duration: 10 days if recovered, 14 days if not recovered by day 10 or for resistant strains 2, 1
Neisseria meningitidis:
- Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours OR benzylpenicillin 2.4g IV every 4 hours 2, 1
- Duration: 5 days 1
Listeria monocytogenes:
Haemophilus influenzae:
Special Considerations
Antimicrobial Resistance:
- Check recent travel history to countries with high pneumococcal resistance rates 2, 1
- Consult local infectious disease expertise for up-to-date resistance patterns 2
- Resources for resistance data: European Centre for Disease Prevention and Control website or World Health Organisation (http://bit.ly/1Kosckx and http://bit.ly/1rOb3cx) 2
Administration Considerations:
- Ceftriaxone should be administered intravenously by infusion over a period of 30 minutes 3
- Do not use diluents containing calcium with ceftriaxone due to risk of precipitation 3
- Concentrations between 10 mg/mL and 40 mg/mL are recommended for IV administration 3
Clinical Evidence:
- Third-generation cephalosporins have demonstrated excellent bactericidal activity against common meningitis pathogens and good penetration of inflamed meninges 2, 4
- Ceftriaxone maintains cerebrospinal fluid concentrations 10-100 times higher than the MIC of pathogenic bacteria for 24 hours after dosing 5
- High-dose cefotaxime (300 mg/kg/day) has been effective in treating pneumococcal meningitis with decreased susceptibility to cephalosporins 6
Important Caveats
- Empirical therapy should be started immediately after obtaining blood cultures and before lumbar puncture results are available 1
- For viral meningitis caused by varicella-zoster virus, the treatment differs significantly - intravenous aciclovir (10-15 mg/kg three times daily) is recommended instead of antibiotics 7
- Meningococcal resistance to penicillin is extremely rare, but pneumococcal resistance varies geographically 2
- Consider adjunctive dexamethasone therapy, especially for pneumococcal meningitis 1
- In cases with no identified pathogen, treatment can be discontinued if clinical recovery occurs by day 10 1